Sun Pharmaceutical Industries Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:	524715	NSE Symbol:	SUNPHARMA	P/E :	95.71
ISIN Demat:	INE044A01036	Div & Yield %:	0.94	EPS :	17.82
Book Value:	101.44	Market Cap (Rs. Cr.):	409,218.58	Face Value :	1

Date	Headline
21-Jul-25	Sun Pharma announces top-line results of tildrakizumab 100 mg Phase 3 studies
14-Jul-25	Sun Pharmaceutical Industries launches LEQSELVI™ (deuruxolitinib) 8 mg tablets in United States
12-Jul-25	Sun Pharmaceuticals Industries to table results
14-Jun-25	Sun Pharma updates on US FDA inspection
23-May-25	Board of Sun Pharmaceutical Industries appoints director
22-May-25	Board of Sun Pharmaceuticals Industries recommends final dividend
12-May-25	Sun Pharmaceuticals Industries announces board meeting date
24-Apr-25	Sun Pharma and Israel-based Moebius Medical publish two articles on MM-II
10-Apr-25	Sun Pharma receives favourable ruling in preliminary injunction delaying launch of LEQSELVI™
07-Apr-25	Sun Pharmaceutical launches Fexuprazan tablets 40 mg in India

Company Snapshot